Patients Don’t Support Prescription Price Hikes (And Neither Does Clinical Evidence) - November 17, 2021
...Muscular Dystrophy News Today captured just how egregious such a price was relative to prices in the rest of the world: “Largely, outrage focused on the fact that the key ingredient in Emflaza, deflazacort, is a corticosteroid — and these steroids, including deflazacort, have long been used in other countries to slow the decline in muscle strength in boys with Duchenne MD.
Read MorePatients Don’t Support Prescription Price Hikes (And Neither Does Clinical Evidence) - November 17, 2021
Highlighting reporting on prescription drug prices in the United States is, to put it plainly, quite depressing.
HHS and FDA Drug Importation Idea: Important Takeaways - July 20, 2018
Azar is proposing a discussion about allowing imports of single-source drugs to lower costs
Yesterday, Health and Human Services Secretary Alex Azar announced that he was tasking FDA Commissioner Scott Gottlieb with forming a working group to explore how drug importation could be used to lower prices. See Gottlieb’s remarks on the proposal.
The crux of the proposal is very narrow.
...More analysis on Gleostine and CeeNu
Emflaza (deflazacort). The launch price in the U.S. was slated to be $89,000/year in 2017, but the drug company responsible, Marathon Pharmaceuticals, postponed the launch due to outrage about the price. The U.S. version was sold to PTC Therapeutics. One foreign version is licensed by Sanofi in the UK sold under the brand-name Calcort.
A Drug Importation Vocabulary Lesson: Misbranded and Unapproved Drugs - December 29, 2017
Words matter when it comes to drug importation
As we close out 2017, personal drug importation via online pharmacies remains a viable lifeline for American patients who can’t afford prices at their local pharmacies. Recent FDA actions against pharmacy storefront offices in Florida, ones that help Americans buy more affordable meds internationally, are troubling.
...One telling example is the drug deflazacort, a steroid used to treat Duchenne muscular dystrophy (DMD). That medication, available in other countries, was “unapproved” by the FDA for the treatment of DMD. American parents imported it for years from the UK, for their children with DMD, at a price of about $750 for a year supply of pills.
Do Board Members of PhRMA Support Importing Unapproved Medication? - February 22, 2017
Since Americans started importing medications for personal use in larger numbers at the beginning of the last decade, the Pharmaceutical Researchers and Manufacturers of America (PhRMA), Big Pharma, has engaged in media and government relations scare tactics to try and stop them.
...To summarize: some folks are outraged because Emflaza (deflazacort) was launched at a price of $89,000 for a one year supply. This seems insane when foreign versions of deflazacort, which cost 1% that amount (less than $1000), are already imported for personal use.
What Emflaza’s Postponed Launch Says about Personal Drug Importation - February 17, 2017
Unapproved but safe and effective… Personal drug importation works! This week, drug company Marathon announced it is postponing the launch of Emflaza, its recently FDA-approved version of an off-patent drug called deflazacort, in the face of heavy scrutiny by Senator Bernie Sanders and Congressman Elijah Cummings over its price tag – $89,000 a year.
PharmacyChecker Recognized by JAMA as Key Resource for Finding Reputable Online Pharmacies - October 21, 2024
White Plains, New York – October 21, 2024 – PharmacyChecker, a trusted platform for verifying international online pharmacies and comparing prescription drug prices, has been recognized in a recent Journal of the American Medical Association (JAMA) article as a valuable resource "to find a reputable online pharmacy that can supply high-quality prescription drugs." Authored by healthcare professionals from Brigham and Women’s Hospital and Harvard Medical School, the article “Strategies to Help Patients Navigate High Prescription Drug Costs” acknowledges the role of international online pharmacies and PharmacyChecker in helping patients manage high prescription drug costs in the United States.
PharmacyChecker Announces Ross Phan as Director of Pharmacy Verification and Information - April 22, 2024
White Plains, NY – April 22, 2024 – PharmacyChecker.com announces today that the company has hired Ross Phan, PharmD, MBA, BCACP, BCGP, BCPS as Director of Pharmacy Verification & Information. Dr.
PharmacyChecker Statement on Federal Court’s Denial of LegitScript’s Motion to Block Antitrust Lawsuit - January 8, 2024
White Plains, New York – January 8th, 2024 – In response to U.S. District Judge Michael H.
PharmacyChecker Introduces List of Trusted Telemedicine Providers - June 20, 2023
White Plains, New York – June 20th, 2023 – PharmacyChecker, a company known for its international online pharmacy verification program and drug price comparisons, is pleased to announce the launch of its list of trusted telemedicine providers.
The total price includes shipping fees which typically cover an entire order, making it more economical to purchase multiple medications in the same order.
U.S. government officials have stated that individuals who order non-controlled prescription drugs from Canada or other foreign sources (up to a three-month supply) for their own use are not being pursued or prosecuted - although it is technically not legal for individuals to import most prescription drugs. The U.S FDA regulates the safety and efficacy of medications sold in U.S. pharmacies. Medications dispensed from outside the U.S. are regulated for safety and efficacy by pharmaceutical/pharmacy regulatory authorities in other countries. Read how regulations may differ by country.
PharmacyChecker provides free monthly email updates of the latest prices.
icon means that this online pharmacy only ships from dispensing pharmacies located in Canada. Separately, the Tier 1 icon means that an online pharmacy accredited by PharmacyChecker only fills prescription orders through their own pharmacy or dispensing pharmacy partners in Australia, Canada, Israel, New Zealand, United Kingdom, or the U.S. Such countries are known to have equally advanced pharmaceutical and pharmacy regulatory systems. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.
icon means that this online pharmacy accredited by PharmacyChecker fills prescription orders through either their own pharmacy or dispensing pharmacy partners located in Australia, India, Mauritius, New Zealand, Turkey, the UK, or Canada. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.